BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

Clinical trial NCT00447122 · TERMINATED

Trial details

NCT number: NCT00447122
Sponsor: Brown University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2007-03-01
Primary completion: 2008-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.